​

Funding Round

Series B - Iterative Scopes

Series B - Iterative Scopes

Investment Firm

Overview

Iterative Scopes delivers tools for physicians and life sciences in colorectal cancer and inflammatory bowel disease space.

Announced Date

Jan 19, 2022

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Clearlake Capital Group

Clearlake Capital Group

Clearlake Capital Group is a early_stage_venture and private_equity and secondary_market and venture firm.

Insight Partners

Insight Partners

Insight Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

5

Investor Name
Participant InvestorBreyer Capital
Participant InvestorEli Lilly
Participant InvestorObvious Ventures
Participant InvestorInsight Partners
Participant InvestorClearlake Capital Group

Round Details and Background

Iterative Scopes raised $150000000 on 2022-01-19 in Series B

Iterative Scopes delivers tools for physicians and life sciences in colorectal cancer and inflammatory bowel disease space.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 22, 2021
Seed Round - Iterative Scopes
1-undefined
Aug 03, 2021
Series A - Iterative Scopes
8-30.0M
Jan 19, 2022
Series B - Iterative Scopes
7-150.0M
Oct 14, 2019
Series A - Iterative Scopes
1-100.0K

Recent Activity

There is no recent news or activity for this profile.